Yijiada

Shanghai, China Founded: 2021 • Age: 5 yrs
Developer of medical devices for urological diseases

About Yijiada

Yijiada is a company based in Shanghai (China) founded in 2021. Yijiada operates in a competitive market with competitors including Advanced MedTech, Halt Medical, Promedon, Uramix and EMD Medical, among others.

  • Headquarter Shanghai, China
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bettermedtech.com
Operational Areas
Key Metrics

Funding Insights of Yijiada

  • Total Rounds 1
  • Investors Count 3

All 1 funding rounds of Yijiada with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2024–Seed–Sunland Fund, Vision Plus Capital
Valuation history

3 investors in total: 3 institutional.

Investors in Yijiada

Yijiada has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Sunland Capital, Vision Plus Capital and Lotus Lake Capital Management.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Sunland Capital is focused on early-stage healthcare industry investments.
2014sunlandfund.comShanghai, China
Venture capital fund focused on multiple sectors
–visionpluscapital.comHangzhou, China
-
–tsinghua-vc.com-
Premium access

Investor details for Yijiada

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Yijiada

2 dated milestones of Yijiada across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Yijiada is founded.
  2. Funding First funding round.

Competitors of Yijiada

Yijiada operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced MedTech, Halt Medical, Promedon, Uramix and EMD Medical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
advanced-medtech.com1990Singapore–11
Provides medical devices for urology and robotic surgery worldwide.
haltmedical.com2005Brentwood, United States$158.58M24
Developer of a device for the removal of uterine fibroids
promedon.com1985Cordoba, Argentina––
Provides medical devices and solutions for healthcare professionals and institutions.
uramix.com1998Lansdowne, United States––
Surgical devices for urological treatments are developed and distributed.
emdmedical.com1999Ostim, Turkey––
Medical equipment with applications in Urology
uropharma.com2012Minneapolis, United States––
Therapeutic solutions for urological and urogynecological diseases are developed.
direxgroup.com1983Petah Tikva, Israel––
Develops medical devices focused on urology solutions.
prosurg.com1989San Jose, United States––
Develops and markets medical devices for prostate and gynecological procedures.
silvoguard.com2020Pune, India–6
Manufactures antimicrobial medical devices for infection prevention in hospitals.
Premium access

Detailed competitors of Yijiada

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Yijiada

Premium access

Complete news archive for Yijiada

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Yijiada

10 companies that operate in the same segment as Yijiada (Genitourinary Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Sacral neuromodulation devices are developed for urinary and bowel control.
2013Irvine, California, United StatesUSD 143.47 M––
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
2012Malvern, Pennsylvania, United StatesUSD 104.6 MUSD 80.28 M209
Therapeutics for infectious and autoimmune diseases are developed.
2010Cambridge, Massachusetts, United StatesUSD 470.49 M–71
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
2014Santa Clara, California, United StatesUSD 123.59 M––
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer
2018Maple Grove, Minnesota, United StatesUSD 157 M–29
A device is developed to treat urinary obstruction from BPH.
2014Palo Alto, California, United StatesUSD 48 M–25
Minimally invasive devices in urology
2004Mountain View, California, United StatesUSD 137.96 M–119
Diagnostic devices for lower urinary tract diseases are developed.
2021Aliso Viejo, California, United StatesUSD 94.99 M–23
Medical device for benign prostatic hyperplasia treatment is developed.
2021Milwaukee, Wisconsin, United StatesUSD 54.16 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Yijiada

Yijiada was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Yijiada is headquartered in Shanghai, China.

Founded in 2021 and based in Shanghai, China, medical devices for urological conditions are developed by the company. Focus is placed on innovative products addressing benign prostatic hyperplasia, urinary incontinence, kidney stones, and tumor treatments. Operations center on creating precise solutions within the medtech sector, with emphasis on comprehensive therapeutic options for these health issues.

Yijiada's top competitors include Halt Medical, EMD Medical and UroPharma.

Yijiada has 3 investors. Key investors include Sunland Capital, Vision Plus Capital, and Lotus Lake Capital Management.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available